INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-66 Cr | ₹413 Cr | ₹-4.41 Cr | ₹14 Cr | ₹1.03 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDSWIFT LABORATORIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-66 Cr |
| Mar2024 | ₹413 Cr |
| Mar2023 | ₹-4.41 Cr |
| Mar2022 | ₹14 Cr |
| Mar2021 | ₹1.03 Cr |
How is Net Cash Inflow / Outflow of INDSWIFT LABORATORIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-66 Cr | Negative | |
| Mar2024 | ₹413 Cr | Positive | |
| Mar2023 | ₹-4.41 Cr | Negative | |
| Mar2022 | ₹14 Cr | 1,276.97 | |
| Mar2021 | ₹1.03 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹1,862.2 Cr | 2.5% | 27.1% | 83.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 0.5% | 4.6% | 11.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | -0.6% | 2.2% | -0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 3.2% | 8.1% | 43.9% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 1.1% | 5.6% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.3% | 5.6% | -0.1% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | 2.5% |
27.1% |
83.3% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses